Income Statement

Fundamentals - Annual Income Statement

  Year Ending Dec 2016 (Update) Year Ending Dec 2015 (Update) Year Ending Dec 2014 (Update) Year Ending Dec 2013 (Update) Year Ending Dec 2012 (Reclassified)
Net Sales 1.58M 1.54M 1.46M 1.41M 1.43M
Revenue 1.58M 1.54M 1.46M 1.41M 1.43M
Total Revenue 1.58M 1.54M 1.46M 1.41M 1.43M
Cost of Revenue 1.12M 1.09M 1.03M 1.01M 1.03M
Cost of Revenue, Total 1.12M 1.09M 1.03M 1.01M 1.03M
Gross Profit 461.45 455.78 421.61 404.52 396.72
Selling/General/Administrative Expense 234.32 225.18 212.29 204.09 203.59
Labor & Related Expense 1.93 7.52 2.57 1.30 0.36
Selling/General/Administrative Expenses, Total 236.25 232.70 214.86 205.39 203.95
Depreciation 34.28 32.37 29.88 27.70 26.01
Amortization of Intangibles, Operating 0.36 1.13 3.19 4.69 4.51
Depreciation/Amortization 34.64 33.50 33.07 32.39 30.52
Investment Income - Operating 2.06 0.15 3.12 4.98 3.50
Interest/Investment Income - Operating 2.06 0.15 3.12 4.98 3.50
Interest Expense (Income), Net-Operating, Total 2.06 0.15 3.12 4.98 3.50
Litigation 5.26 4.97 2.14 2.15 1.21
Impairment-Assets Held for Use
Loss (Gain) on Sale of Assets - Operating
Other Unusual Expense (Income)
Unusual Expense (Income) 5.26 4.97 2.14 2.15 1.21
Other Operating Expense -- --
Other, Net 4.49 -- 26.22 1.13
Other Operating Expenses, Total 4.49 -- -- 26.22 1.13
Total Operating Expense 1.40M 1.36M 1.29M 1.28M 1.27M
Operating Income 178.75 184.46 168.42 133.39 156.42
Interest Expense - Non-Operating -3.72 -3.65 -8.19 -15.04 -14.72
Interest Expense, Net Non-Operating -3.72 -3.65 -8.19 -15.04 -14.72
Interest Income, Non-Operating 0.38 0.28 -0.03 0.85 0.81
Investment Income, Non-Operating 2.06 0.15 3.12 4.98 3.50
Interest/Investment Income, Non-Operating 2.44 0.43 3.09 5.83 4.31
Interest Income (Expense), Net-Non-Operating, Total -1.27 -3.22 -5.10 -9.21 -10.42
Gain (Loss) on Sale of Assets -0.42 -0.70 -0.64 -0.32 -0.35
Other Non-Operating Income (Expense) -- -0.42 0.07 -0.04 0.16
Other, Net -- -0.42 0.07 -0.04 0.16
Net Income Before Taxes 177.05 180.13 162.75 123.83 145.82
Income Tax – Total 68.31 69.85 63.44 46.60 56.52
Income After Tax 108.74 110.27 99.32 77.23 89.30
Net Income Before Extraordinary Items 108.74 110.27 99.32 77.23 89.30
Discontinued Operations
Total Extraordinary Items
Net Income 108.74 110.27 99.32 77.23 89.30
Income Available to Common Excluding Extraordinary Items 108.74 110.27 99.32 77.23 89.30
Income Available to Common Stocks Including Extraordinary Items 108.74 110.27 99.32 77.23 89.30
Basic Weighted Average Shares 16.38 16.87 17.17 18.20 18.92
Basic EPS Excluding Extraordinary Items 6.64 6.54 5.79 4.24 4.72
Basic EPS Including Extraordinary Items 6.64 6.54 5.79 4.24 4.72
Dilution Adjustment
Diluted Net Income 108.74 110.27 99.32 77.23 89.30
Diluted Weighted Average Shares 16.79 17.42 17.84 18.59 19.34
Diluted EPS Excluding Extraordinary Items 6.48 6.33 5.57 4.16 4.62
Diluted EPS Including Extraordinary Items 6.48 6.33 5.57 4.16 4.62
DPS - Common Stock Primary Issue 1.00 0.92 0.84 0.76 0.68
Gross Dividends - Common Stock 16.44 15.61 14.26 12.54 13.03
Stock-Based Compensation, Supplemental 8.33 5.45 4.80 8.13
Interest Expense, Supplemental 3.72 3.65 8.19 15.04 14.72
Interest Capitalized, Supplemental
Depreciation, Supplemental 34.28 32.37 29.88 27.70 26.01
Litigation Charge, Supplemental 0.05 0.18 0.45 26.33 1.76
Other Unusual Expense (Income), Supplemental 0.04 0.02 0.36 2.53
Non-Recurring Items, Total 0.05 0.21 0.47 26.69 4.28
Total Special Items 5.73 5.89 3.25 29.16 5.84
Normalized Income Before Taxes 182.78 186.01 166.01 152.99 151.66
Effect of Special Items on Income Taxes 2.21 2.28 1.27 10.98 2.26
Income Taxes Excluding Impact of Special Items 70.52 72.13 64.70 57.58 58.78
Normalized Income After Taxes 112.26 113.88 101.30 95.41 92.88
Normalized Income Available to Common 112.26 113.88 101.30 95.41 92.88
Basic Normalized EPS 6.85 6.75 5.90 5.24 4.91
Diluted Normalized EPS 6.69 6.54 5.68 5.13 4.80
Amortization of Intangibles, Supplemental 0.36 1.13 3.19 4.69 4.51
Rental Expense, Supplemental 40.03 40.02 39.61 38.99 40.00
Advertising Expense, Supplemental
Audit-Related Fees, Supplemental 2.05 1.93 1.91 1.89 1.68
Audit-Related Fees 0.14 0.13 0.13 0.13 0.13
Tax Fees, Supplemental -- -- -- --
All Other Fees Paid to Auditor, Supplemental -- -- -- --
Gross Margin 29.26 29.53 28.95 28.62 27.74
Operating Margin 11.34 11.95 11.57 9.44 10.94
Pretax Margin 11.23 11.67 11.18 8.76 10.20
Effective Tax Rate 38.58 38.78 38.98 37.63 38.76
Net Profit Margin 6.90 7.14 6.82 5.46 6.24
Normalized EBIT 186.12 189.79 174.15 167.22 165.41
Normalized EBITDA 220.75 223.29 207.22 199.61 195.94
Current Tax - Domestic 64.70 55.03 48.58 45.35 51.47
Current Tax - Foreign 0.39 0.40 0.60 0.51 0.39
Current Tax - Local 9.93 8.10 7.29 7.73 7.81
Current Tax - Total 75.02 63.53 56.46 53.59 59.67
Deferred Tax - Domestic -6.71 6.32 6.97 -7.00 -3.27
Deferred Tax - Foreign 0.01 0.00 0.01 0.01 0.12
Deferred Tax - Total -6.71 6.33 6.98 -6.99 -3.15
Income Tax - Total 68.31 69.85 63.44 46.60 56.52
Defined Contribution Expense - Domestic 14.47 11.97 13.84 14.51 11.38
Total Pension Expense 14.47 11.97 13.84 14.51 11.38
Number of Discharges 64.69M 64.90M 63.48M 63.00M 63.20M
Net Inpatient Revenues 97.58 99.44 102.88 104.97 114.49
For a more complete picture of our financial results, please review our SEC Filings

In millions of USD (except for per share items)

Copyright Thomson Reuters Corporation

All information current at time of original publication. Read complete disclaimer for details.
Copyright © 2017, Chemed Corporation. All rights reserved.
Page last modified: 04/18/05